Frontlight ResearchEarly access
Trial site
Comprehensive Cancer Centers of Nevada
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Colorectal cancer2 trials
- Metastatic breast cancer2 trials
- Chronic lymphocytic leukaemia1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Myelodysplastic syndromes1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 39 trials
- Phase 23 trials
- Phase 11 trial
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Pfizer3 trials
- Hoffmann-La Roche2 trials
- Revolution Medicines, Inc.2 trials
- BioAtla, Inc.1 trial
- Erasca, Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Completed
Completed
Completed
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026